Potter, Barry, 2002. Therapeutics. A61K31/7084-WO02098397 (A2), 12 December 2002.
Related documents:This repository does not currently have the full-text of this item.
You may be able to access a copy if URLs are provided below.
The use of a compound of formula (Ia): wherein A and B are independently selected from a cyclic ring, wherein each of which cyclic rings A and B may be optionally substituted at least one ring position; and L is a suitable linker; or a pharmaceutically acceptable salt thereof, in the manufacture of a medicament for use in inhibiting ADP-ribosyl cyclase.
|Creators||Potter, B., Guse, A. H., Mayr, G. W. and Schweitzer, K.|
|Departments||Faculty of Science > Pharmacy & Pharmacology|
Actions (login required)